These beneficial effects can be reversed by the TRPM8 antagonist AMTB or lidocaine, or by Trpm8 knockout, highlighting TRPM8's therapeutic potential in ischemic stroke treatment. The gene discussed is TRPM8; the disease is ischemic stroke.